Gaspar J

Language: Spanish
References: 9
Page: 261-264
PDF size: 158.79 Kb.

Text Extraction

No abstract

REFERENCES

1. Grüntzig A: Transluminal dilatation of coronary-artery stenosis. Lancet 1978; 1: 263.

2. Braunwald E: Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia. W.B.Saunders Co., 1980, p:304.

3. Zipes DP, Lobby P, Bonow RO, Braunwald E: Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. 7a Ed. Philadelphia. Elsevier Saunders, 2005.

4. Boden WE, O’ROurke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.

5. Serruys PW, Daemen J: Late stent thrombosis. A nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115: 1433-1439.

6. Katritsis DG, Ioannidis JP: Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery diease: a meta-analysis. Circulation 2005; 111: 2906-2912.

7. Cannon CP, Braunwald E: Unstable Angina and Non-ST Elevation Myocardial Infarction En: Zipes DP, Lobby P, Bonow RO, Braunwald E: Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. Séptima Edición Philadelphia. Elsevier Saunders. 2005, p: 1243-73.

8. Stenestrand U, Lindbäck J, Wallentin L: Long-term outcome of primary percutaneous coronary intervention vs pre-hospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006; 295: 1749-1756.

9. Rissanen TT, Ylä-Herttuala S: The current status of cardiovascular gene therapy. Mol Ther 2007; 15: 1233-47.